| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 347,046 | 453,503 | 419,753 | 683,464 | | Cost of Revenue | 281,621 | 296,690 | 342,957 | 495,883 | | | Gross Profit | 65,425 | 156,813 | 76,796 | 187,581 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 17,300 | 26,466 | 20,268 | 12,498 | | Non Recurring | 4,774 | (1,522) | (3,252) | (56,237) | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 54,231 | 131,869 | 59,780 | 231,320 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 725 | 1,165 | 1,810 | 4,040 | | Earnings Before Interest And Taxes | 54,956 | 133,034 | 61,590 | 189,695 | | Interest Expense | 6,762 | 6,757 | 6,728 | 6,782 | | Income Before Tax | 48,194 | 126,277 | 54,862 | 182,913 | | Income Tax Expense | 5,049 | 38,215 | 12,585 | 10,109 | | Minority Interest | (2,972) | (9,474) | (7,908) | (15,315) | | | | Net Income From Continuing Ops | 65,472 | 80,474 | 29,995 | 164,081 | | | Non-recurring Events | | Discontinued Operations | 810 |
-
|
-
| 657 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 45,928 | 80,474 | 29,995 | 164,738 | | Preferred Stock And Other Adjustments | (17) | (17) | (17) | (69) | | | Net Income Applicable To Common Shares | $45,911 | $80,457 | $29,978 | $164,669 |
|
1.48% Nasdaq 
Income Statement
